Difference between revisions of "WSI22-122-Case-3"

From MGH Learn Pathology
(Created page with "{{ServiceRequestCase |requisition=CCSP 2022 |subject=MGH |intent=order |occurrenceDateTime=2022/10/24 13:15 |basedOn=WSI22-122 |priority=routine |code=study |orderDetail=case...")
 
Line 25: Line 25:
 
|reasonCode=H&E
 
|reasonCode=H&E
 
|view=show
 
|view=show
|modality=mrxs
+
|modality=tiff
 
}}
 
}}
 
{{Media
 
{{Media
Line 35: Line 35:
 
|reasonCode=CDX2
 
|reasonCode=CDX2
 
|view=show
 
|view=show
|modality=mrxs
+
|modality=tiff
 
}}
 
}}
 
{{Media
 
{{Media
Line 45: Line 45:
 
|reasonCode=Synaptophysin
 
|reasonCode=Synaptophysin
 
|view=show
 
|view=show
|modality=mrxs
+
|modality=tiff
 
}}
 
}}
 
{{Media
 
{{Media
Line 55: Line 55:
 
|reasonCode=Chromogranin A
 
|reasonCode=Chromogranin A
 
|view=show
 
|view=show
|modality=mrxs
+
|modality=tiff
 
}}
 
}}

Revision as of 13:47, September 12, 2022

WSI22-122-Case-3
43 year old woman with a colon mass and abdominal carcinomatosis, s/p chemotherapy
Adenocarcinoma with neuroendocrine differentiation, likely secondary to treatment effect
October 24, 2022 12:30:00 PM